Inspiratory flow profiles of patients with severe COPD achieved through Autohaler, Diskus, Turbohaler and in vitro assessment of corresponding output characteristics Source: Eur Respir J 2003; 22: Suppl. 45, 409s Year: 2003
Budesonide/formoterol in a single inhaler improves asthma control more effectively than a higher dose of fluticasone Source: Eur Respir J 2001; 18: Suppl. 33, 21s Year: 2001
Salmeterol/fluticasone propionate combination (SFC) inhaler is associated with greater levels of compliance in children than other regular asthma medications Source: Eur Respir J 2002; 20: Suppl. 38, 431s Year: 2002
A comparison of the efficacy of low dose single inhaler budesonide/formoterol given once and twice daily in patients with mild- to- moderate asthma Source: Eur Respir J 2007; 30: Suppl. 51, 615s Year: 2007
Efficacy of combined budesonide/formoterol delivered via turbuhaler on lung function and asthma control in asthmatic children Source: Eur Respir J 2003; 22: Suppl. 45, 496s Year: 2003
Sustained FEV1 increases in COPD patients induced by salmeterol 50 mcg twice daily via the diskus inhaler Source: Eur Respir J 2002; 20: Suppl. 38, 240s Year: 2002
Effect of combination fluticasone propionate and salmeterol diskhaler in treatment of moderate to severe asthma: comparison of initial high dose, constant medium dose and placebo Source: Eur Respir J 2001; 18: Suppl. 33, 123s Year: 2001
Low dose salmeterol/fluticasone propionate combination (SFC) via metered dose inhaler (MDI) improves asthma control and quality of life in patients not well controlled on inhaled steroids (ICS) Source: Eur Respir J 2002; 20: Suppl. 38, 47s Year: 2002
Superior efficacy of a low daily dose of a new fixed combination of beclometasone dipropionate/formoterol pMDI compared to an increased daily dose of BDP in moderate persistent asthma: a 3 month clinical study Source: Eur Respir J 2006; 28: Suppl. 50, 207s Year: 2006
Cardiovascular effects of a high dose of the budesonide/formoterol single inhaler in asthmatic patients Source: Eur Respir J 2001; 18: Suppl. 33, 54s Year: 2001
High dose inhaler corticosteroids in patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 289s Year: 2004
Budesonide/formoterol in a single inhaler is more effective than a higher dose of inhaled corticosteroids in patients with mild persistent asthma Source: Eur Respir J 2002; 20: Suppl. 38, 387s Year: 2002
Budesonide and formoterol in a single inhaler controls exacerbations more effectively than a higher dose of inhaled corticosteroids alone, in mild-moderate persistent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 43s Year: 2001
High lung deposition of 99m Tc-labelled ciclesonide administered via HFA-MDI to asthma patients Source: Eur Respir J 2004; 24: Suppl. 48, 583s Year: 2004
Healthcare costs are reduced when asthma is treated with budesonide and formoterol in a single inhaler compared with the same medication via separate inhalers Source: Eur Respir J 2001; 18: Suppl. 33, 54s Year: 2001
Formoterol: a new pMDI CFC free formulation. Efficacy of the 12µg dosage versus a dry powder inhaler in moderate to severe asthmatic patients Source: Eur Respir J 2003; 22: Suppl. 45, 284s Year: 2003
Comparison of HFA fluticasone-formoterol combination pressurized meter dose inhaler (pMDI) and HFA budesonide-formoterol combination pMDI in patients with moderate to severe persistent asthma Source: Annual Congress 2010 - Drug delivery and pharmacokinetics II Year: 2010
The anti-inflammatory effect of budesonide 800 μg/day via Easyhaler® compared with the same dose of budesonide via Turbuhaler® in adult asthmatics Source: Eur Respir J 2001; 18: Suppl. 33, 337s Year: 2001
Formoterol provides comparable bronchodilatation when delivered via dry powder (DPI) and metered dose inhalers (MDI) in adult asthma patients Source: Eur Respir J 2005; 26: Suppl. 49, 339s Year: 2005
Addition of an extra dose of salmeterol (S) diskus to conventional dose of S diskus in patients with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 177s Year: 2001